Sepracor, Inc. (SEPR) Announces Resignation of Adrian Adams as President and CEO and Plans for Merger with Daiichi Suntory Pharma Co., Ltd.
2/19/2010 6:23:32 AM
More...
|
Daiichi Suntory Pharma Co., Ltd. to Move Clot Prevention Drug to Phase 3
10/31/2008 6:30:06 AM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Initiates Phase 3 Clinical Trial Of Phenoptin For PKU
10/19/2005 5:13:14 PM
More...
|
Yamanouchi Pharmaceutical Co., Ltd. Terminates Marketing Agreement With Daiichi Suntory Pharma Co., Ltd.
10/19/2005 5:12:46 PM
More...
|
Torre Lazur McCann Creates Consumer Group
10/19/2005 5:12:22 PM
More...
|
Daiichi Suntory Pharma Co., Ltd., BioMarin Pharmaceutical Inc. (BMRN) To Enter Into Licensing Agreement For Phenoptin For The Treatment Of PKU
10/19/2005 5:12:19 PM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Forms Strategic Partnership With Daiichi Suntory Pharma Co., Ltd. For Phenoptin To Treat Phenylketonuria
10/19/2005 5:12:17 PM
More...
|
Daiichi Pharmaceutical (JPN) Acquires Daiichi Suntory Pharma Co., Ltd. As Wholly Owned Subsidiary For 20 Billion Yen
10/19/2005 5:12:11 PM
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Acquires Rights To Daiichi Suntory Pharma Co., Ltd.'s 6R-BH4 For Treating Vascular Dysfunction In Diabetes And Cardiovascular Disease
10/19/2005 5:10:30 PM
More...
|
Daiichi Suntory Pharma Co., Ltd. To Change Its Name To Daiichi Asubio Pharma
10/19/2005 5:09:46 PM
More...
|
|